Axa’s LAVA Therapeutics LVTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-225,748
| Closed | -$375K | – | 1130 |
|
|
2023
Q1 | $375K | Sell |
225,748
-1,733
| -0.8% | -$2.88K | ﹤0.01% | 997 |
|
|
2022
Q4 | $796K | Sell |
227,481
-1,190
| -0.5% | -$4.17K | ﹤0.01% | 923 |
|
|
2022
Q3 | $1.05M | Buy |
228,671
+1,198
| +0.5% | +$5.48K | ﹤0.01% | 853 |
|
|
2022
Q2 | $671K | Sell |
227,473
-4,413
| -2% | -$13K | ﹤0.01% | 933 |
|
|
2022
Q1 | $1.02M | Buy |
231,886
+2
| +0% | +$9 | ﹤0.01% | 950 |
|
|
2021
Q4 | $1.28M | Buy |
231,884
+2,763
| +1% | +$15.2K | ﹤0.01% | 918 |
|
|
2021
Q3 | $1.36M | Buy |
229,121
+8,458
| +4% | +$50.1K | ﹤0.01% | 934 |
|
|
2021
Q2 | $2.4M | Buy |
220,663
+300
| +0.1% | +$3.26K | 0.01% | 856 |
|
|
2021
Q1 | $3.35M | Buy |
+220,363
| New | +$3.35M | 0.01% | 769 |
|